Rs10494366

From SNPedia

Jump to: navigation, search
is asnp
is mentioned by
dbSNPrs10494366
hapmaprs10494366
hgdprs10494366
ensemblrs10494366
gopubmedrs10494366
scholarrs10494366
googlers10494366
pharmgkbrs10494366
hgvbaseg2prs10494366
medrefsnprs10494366
23andMers10494366
SNP Nexus

GeneNOS1AP
Chromosome1
Orientationplus
Position160352308
GenotypeEffect
rs10494366(G;G)Long QT interval
rs10494366(G;T)average QT interval
rs10494366(T;T)Shorter QT interval


Genotypes Magnitude Summary
Rs10494366(G;G) Long QT interval
Rs10494366(G;T) 00 average QT interval
Rs10494366(T;T) 22 Shorter QT interval
rs10494366, a SNP in the NOS1AP gene encoding the nitric oxide synthase I adaptor protein, accounts for some of the variation seen in abnormal heart rhythms, in particular, the QT interval. Based on studies totaling ~4,000 individuals of Caucasian ancestry, homozygotes for one allele have shorter QT intervals, while homozygotes for the other allele have a longer QT interval. [PMID 16648850]

A follow-up study determined that one rs10494366(G) allele was associated with a 3.8-ms (CI: 3.0 - 4.6ms, p=7.8x10(-20)) increase in QT interval duration, and two (G) alleles had twice that increase. No increase in risk for sudden death due to a cardiac problem was associated with this SNP, though. [PMID 17576865]

[PMID 18235038] rs10494366 minor homozygotes had a 9.3 msec longer QT interval compared to major homozygotes (p=5.7x10(-5)); rs10918594 minor homozygotes had a 12.5 msec longer QT interval compared to major homozygotes (p=1.5x10(-6)). Restricting analyses to the diabetic EAs strengthened the effect despite the reduction in sample size (11.3 msec difference, p=5.1x10(-5); 13.9 msec difference, p=1.6x10(-6), respectively).

[PMID 18551039] Patients with rs10494366(G;T) or (G;G) genotypes have an increased mortality risk (hazard ratio 2.8) compared to (T;T) genotypes upon treatment with sulfonylurea antidiabetic drugs. Glibenclamide is less effective in reducing glucose levels and mortality rates were higher compared with glibenclamide users with the (T;T) genotype. However, in tolbutamide and glimepiride users, the (G;T) and (G;G) genotypes were associated with a reduced mortality rate.

[PMID 19204306] rs10494366, rs4657139 and rs16847548 were significantly associated with adjusted QT interval in whites. relative hazard of SCD associated with each C allele at rs16847548 was 1.31. rs12567209 was also independently associated with SCD in whites (relative hazard 0.57, 95% confidence interval 0.39 to 0.83, P=0.003). No significant associations observed in blacks.

? (G;G) (G;T) (T;T)
GWAS
SNP rs10494366
PubMedID [PMID 16648850]
Condition QT interval prolongation
Gene NOS1AP
Risk Allele
pValue 1.00E-010
OR 4.9
95% CI 7.90 (NR) msec difference between homozygote


[PMID 19247217] Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation

Related to QT INTERVAL, VARIATION IN according to omim 610141. See also


[PMID 19943157] NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study

PharmGKBPA161748484
Name
AnnotationThis variant in intron 1 of the NOS1AP gene has been associated with resting QTc in a genome-wide association scan and replicated in independent populations.
GeneNOS1AP
Featue
EvidencePubMed ID:16648850; PubMed ID:17565224; PubMed ID:17576865; PubMed ID:18511491
Drugs
Diseases
Curation LevelCurated


[PMID 19289301] SNP association and sequence analysis of the NOS1AP gene in SIDS

GWAS snp
PMID [PMID 20062063]
Trait Electrocardiographic traits
Title Several common variants modulate heart rate, PR interval and QRS duration
Risk Allele G
P-val 5E-22
Odds Ratio 12.20 [9.72-14.68] % SD increase


[PMID 20215044] Relationship of Common Candidate Gene Variants to Electrocardiographic T-Wave Peak to T-Wave End Interval and T-Wave Morphology Parameters